PTX 0.00% 4.3¢ prescient therapeutics limited

Ann: PTX unveils new clinic-ready CAR-T enhancement platform, page-24

  1. 4,336 Posts.
    lightbulb Created with Sketch. 2023
    What a great pivot for PTX. Its becoming a stop shop for CarT treatment enhancement. I like how this cell improvement and OmniCar can be licenced to third parties either together or individually. The market potential is huge.

    Will be interesting to see this at work when the OmniCar GBM trial hits arms.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.3¢
Change
0.000(0.00%)
Mkt cap ! $34.62M
Open High Low Value Volume
4.3¢ 4.4¢ 4.3¢ $252 5.87K

Buyers (Bids)

No. Vol. Price($)
4 329464 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 35000 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.